
Retatrutide is a triple hormone (GIP, GLP-1 and glucagon) receptor agonist in development for the treatment of obesity.

Product Name | Tirz |
CAS NO. | Tirz |
Other name | Tirz |
Appearance | White freeze-dried powder |
Purity | 98% HPLC |
Application | Research peptides |
Shelf Life | 24 Months |
Storage | Store at a temperature of 2-8 degrees, protected from light. |
- Tirzepatid represents a major breakthrough in the realm of type 2 diabetes management. By combining the effects of GLP-1 agonists and GIP receptor agonists, this injectable medication is able to effectively regulate blood sugar levels like never before.
Not only does Tirzepatid help patients control their blood sugar, but it also promotes weight loss - a valuable feature for individuals struggling with obesity and diabetes concurrently. With just one injection required weekly, Tirzepatide offers a convenient treatment option for those with busy lifestyles.






